MSLN and Patent ductus arteriosus: MSLN is a glycosylphosphatidyl inositol (GPI)-linked protein that is expressed by mesothelial cells lining the peritoneum [175] and highly overexpressed in various types of cancers, such as mesothelioma [176], ovarian cancer [176], gastric cancer [134], and PDA [115, 133].